RVTY

#897
Revvity, Inc.
90.7200 USD
-2.40%
Setor: Cuidados de saúde
Base: USD
Moeda do lucro: USD
Faixa diária
90.5800
91.1100
Faixa anual
83.4800
118.2600
Mudança diária
-2.40%
Mudança mensal
+1.88%
Mudança em 6 meses
-4.36%
Mudança anual
-4.36%
Fechamento anterior
92.9500
Abrir
91.1000
Bid
Ask
Mínimo
90.5800
High
91.1100
Volume
92
Abrir gráfico completo

Financials

Visão geral Relatórios Estatísticas Dividendos
Trimestral Ano
  • Market Capitalization 10.1424 B
  • Employee 11 K
  • Founded N/A
  • CEO Prahlad Singh
  • Website www.revvity.com
  • Headquarter Massachusetts, United States
  • FIGI BBG000FXW512
  • Industry Diagnósticos e pesquisa
Receita total
Lucro líquido
Lucro básico por ação
Dívida total
Fluxo de caixa livre
Caixa e equivalentes de caixa
Índice preço/lucro
46.91
Índice preço/fluxo de caixa
3.96
Dividendos por ação
0.07
Rendimento de dividendos, %
0.29

Revvity Inc

Revvity, Inc. is an American company in the life sciences and diagnostics business that is focused on selling to the pharmaceutical and biotechnology industries, especially in relation to approaches making use of new cell therapy or gene therapy developments. Its origins lie with the long-existing company PerkinElmer, which has been in a variety of business lines. In 2022, a split of PerkinElmer resulted in one part, comprising its applied, food and enterprise services businesses, being sold to the private equity firm New Mountain Capital for $2.45 billion and thus no longer being public but keeping the PerkinElmer name. The other part, comprising the life sciences and diagnostics businesses, remained public but required a new name, which in 2023 was announced as Revvity, Inc. From the perspective of Revvity, the goal of creating a separate company was that its businesses might show greater profit margins and more in the way of growth potential. An associated goal was to have more financial flexibility moving forward. On May 16, 2023, the PerkinElmer stock symbol PKI was replaced by the new symbol RVTY.

Notícias